A recent case exposed major ethical breaches in psychedelic therapy, where a therapist abandoned a client after an ibogaine session, resorting to defamation and manipulation. This highlights the need for strict ethical oversight to ensure professionalism and protect the integrity of the field.

An open-label study on psilocybin (25mg) for severe alcohol use disorder showed promising results. Participants reduced heavy drinking days by 37.5%, drank 3.4 fewer drinks daily, and reported less alcohol craving and increased confidence in staying sober, with mild side effects like anxiety and fatigue.

Psychedelic-assisted therapy offers a transformative approach to anxiety treatment, addressing root causes rather than just symptoms. Psilocybin, LSD, MDMA, ayahuasca, and ketamine enhance neuroplasticity, reduce fear responses, and provide lasting relief, often outperforming traditional medications with fewer side effects.

5-MeO-DMT, derived from the Bufo alvarius toad, has been used for centuries in Indigenous healing practices. Recent scientific research highlights its potential in treating trauma, addiction, and mental health disorders, showing promising results in promoting neuroplasticity and emotional healing.

Discover how psychedelics like ibogaine, ayahuasca, ketamine, MDMA, psilocybin, and more are revolutionising addiction recovery. Explore their potential to heal trauma, rewire the brain, and reduce relapse rates, offering a transformative alternative to traditional rehab models.

Discover a breakthrough in mental health treatment with Dual Sympathetic Reset (DSR) SGB and ketamine infusion therapy. This innovative approach helps reset the nervous system, reduce PTSD, anxiety, and depression symptoms, and promote neuroplasticity. Learn how these treatments can accelerate recovery today.

A Babalawo is a spiritual leader and high priest in the Yoruba religion, skilled in Ifá divination and healing. They guide individuals through spiritual practices, using divination, rituals, and herbal remedies to restore balance, offer wisdom, and connect with the divine and ancestors.

Discover how mescaline, a classic psychedelic, shows promise as a treatment for alcohol use disorder (AUD). Recent studies suggest its potential to rewire the brain, promote neuroplasticity, and aid in addiction recovery. Learn more about its growing therapeutic applications and future prospects.

Psychedelic therapy is growing as a powerful tool for treating mental health conditions, but adherence to professional and ethical guidelines is essential for client safety. This includes respecting boundaries, ensuring informed consent, and maintaining confidentiality. Therapists, clinics, and retreat owners all have a responsibility to uphold these standards to provide safe and effective care.

5-MeO-DMT shows promise in treating alcohol use disorder by helping individuals break addictive patterns, heal trauma, and enhance emotional regulation. Beyond addiction, it offers potential benefits for mental health, including reducing anxiety, depression, and fostering spiritual growth and neuroplasticity.

Ancestral, intergenerational, and transgenerational trauma transcend individual experiences, impacting mental health and collective identities. Psychedelic therapy offers pathways to access and heal these inherited wounds, combining emotional release, somatic healing, and spiritual connection. Rooted in cultural sensitivity, this integrative approach fosters resilience and sustainable recovery.

Ketamine therapy offers rapid relief for PTSD by promoting neuroplasticity and breaking maladaptive patterns. Recent trials show significant symptom reductions within hours. While MDMA and other psychedelics provide lasting benefits, ketamine’s accessibility and established protocols make it a leading option for PTSD treatment.

Psychedelic therapy for addiction treatment, using substances like ketamine, ibogaine, and 5-MeO-DMT, requires structured preparation & integration for optimal outcomes. Proper pre-treatment guidance ensures readiness, while post-treatment integration helps translate insights into lasting change.

Specialised facilities and collaborative programs are key to effective healing & relapse prevention.

Entheogens like psilocybin, MDMA, ketamine, ayahuasca, and iboga are showing promise in treating mental health conditions such as depression, PTSD, addiction, and anxiety. Recent studies in 2024 highlight their potential, offering new hope for individuals with treatment-resistant disorders, though more research is needed.

Iboga therapy involves three main substances: iboga, ibogaine, and total alkaloids (TA). Iboga is used in traditional spiritual ceremonies, while ibogaine is a potent compound used for addiction treatment, though with cardiovascular risks. TA offers a milder, safer alternative, showing promise in recovery treatments.

As psychedelic therapy expands, ensuring patient safety through medical oversight and ethical standards is critical. This includes screening for health conditions, informed consent, and post-session support. With the rise of retreats and underground therapy, maintaining rigorous practices is essential for safe treatment.

Psychedelics are gaining ground in mental health, with research highlighting their role in neuroplasticity and wider therapeutic uses. Entheogens like ketamine, psilocybin, and MDMA show promise in treating depression, PTSD, and addiction, potentially transforming mental health care through lasting brain changes.

Iboga and psilocybin together offer powerful healing for addiction, ancestral trauma, and holistic recovery. Their complementary effects require safe, ethical protocols. A psychedelic concierge service can help clients design personalized, secure programs and connect with qualified, trusted providers.

The Demand is growing for private psychedelic retreats that prioritize confidentiality and tailored care, aligning with clients' personal needs, schedules, and lifestyles. A concierge service supports this by managing logistics, securing privacy, and providing personalized guidance for a transformative experience

Psychedelic therapy is transforming addiction recovery with faster, more sustainable results than traditional rehabs. Using substances like psilocybin, ayahuasca, ketamine and ibogaine, it addresses the root causes of addiction, offering lower relapse rates and long-term sobriety through deep transformational emotional healing.